Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 14:2021:9033278.
doi: 10.1155/2021/9033278. eCollection 2021.

Evaluation of Antibiotic Resistance and Biofilm Production among Clinical Strain Isolated from Medical Devices

Affiliations

Evaluation of Antibiotic Resistance and Biofilm Production among Clinical Strain Isolated from Medical Devices

Veronica Folliero et al. Int J Microbiol. .

Abstract

Microbial biofilms pose a serious threat to patients requiring medical devices (MDs). Prolonged periods of implantation carry a high risk of device-related infections (DRIs). Patients with DRIs often have negative outcomes following the failure of antibiotic treatment. Resistant DRIs are mainly due to the MDs contamination by bacteria producing biofilm. The present study aimed to detect biofilm formation among MD bacterial isolates and to explore their antibiotic resistance profile. The study was conducted on 76 MDs, collected at University Hospital of Campania "Luigi Vanvitelli," between October 2019 and September 2020. Identification of isolates and antibiotic susceptibility testing were performed using Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) and Phoenix Becton Dickinson, respectively. Biofilm-forming abilities were assessed using the tissue culture plate (TCP) method. Among the 94 MDs isolated strains, 42.7% were Gram-positive, 40.3% Gram-negative, and 17% Candida species. Among 78 bacterial strains, 43.6% were non-biofilm producers while 56.4% produced biofilms. All biofilm producing isolates were sensitive to a limited spectrum of antibiotic classes. All moderate and strong biofilm producers and 81% of weak biofilm producers were Multidrug Resistance (MDR) strains. In contrast, among non-biofilm producers, only 11.8% were classified as MDR strains. Our results highlighted that Sulfamides and Glycopeptides for the major Gram-positive strains and Fluoroquinolones, Carbapenems, and Aminoglycosides for the most represented Gram-negative isolates could be the most suitable therapeutic choice for most biofilm-DRIs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Prevalence of bacterial and yeast strains isolated from medical devices.
Figure 2
Figure 2
Monomicrobial (a), bimicrobial (b), and trimicrobial (c) contamination of the medical devices studied.
Figure 3
Figure 3
Distribution of MDR and NO-MDR bacterial strains isolated from medical devices (p value < 0.05).
Figure 4
Figure 4
Biofilm formation among MD isolates.
Figure 5
Figure 5
Biofilm formation analysis of MD isolates. (a) Biofilm production level of MDR, red bars, and NO-MDR, yellow bars. The green bars indicate negative and positive controls, also represented by SEM. Dashed line represents the cutoff value. (b) Prevalence of MDR and NO-MDR strains among the different biofilm productions. (c) Distribution of biofilm formation with indicated resistance phenotypes.
Figure 6
Figure 6
Susceptibility rate to different classes of antibiotics in E. coli (a), P. aeruginosa (b), K. pneumoniae (c), and CoNS (d) between biofilm and non-biofilm producers. p value< 0.05.

References

    1. Vestby L. K., Grønseth T., Simm R., et al. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics. 2020;9(2):p. 59. - PMC - PubMed
    1. Gebreyohannes G., Nyerere A., Bii C., et al. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 2019;5(8)e02192 - PMC - PubMed
    1. Franci G., Folliero V., Cammarota M., et al. Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase. Scientific Reports. 2018;8:p. 13117. - PMC - PubMed
    1. Sharma D., Misba L., Khan A. U., et al. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrobial Resistance and Infection Control. 2019;8:p. 76. - PMC - PubMed
    1. Qi L., Li H., Zhang C., et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Frontiers in Microbiology. 2016;7:p. 483. - PMC - PubMed